| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414427A2 Kavalactone compositions and methods of use |
| 05/06/2004 | EP1414426A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 05/06/2004 | EP1414387A2 Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1222162B1 Novel ltb4-antagonist, method for the production thereof and its use as a medicament |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1060181B1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 05/06/2004 | CA2503557A1 Osteogenesis promotor containing .beta.-cryptoxanthin as the active ingredient |
| 05/06/2004 | CA2502607A1 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | CA2502453A1 Angiogenesis inducer |
| 05/06/2004 | CA2501228A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494424A IL-8 receptor antagonists |
| 05/05/2004 | CN1493346A Functional medical wine for treating various diseases |
| 05/05/2004 | CN1493344A Medicine for treating osteosis |
| 05/05/2004 | CN1493325A Chinese medicine for treating osteoporosis and its preparation method |
| 05/05/2004 | CN1493303A Extraction method of scorpion active protein liquid |
| 05/05/2004 | CN1493299A Application of akebia saponin D in preparation of medicine for proventing and treating osteo pathic |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
| 05/05/2004 | CN1148353C Phosphatidase A2 inhibitor and its prepn process and use |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/05/2004 | CN1148218C Wind dispelling and cold expelling snake ointment |
| 05/05/2004 | CN1148213C Composite medicine for treating osteoporosis |
| 05/05/2004 | CN1148175C Use of calcium L-threonate in prevention and inhibition of osteoporosis and rickets |
| 05/04/2004 | US6730696 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730299 Kit; simple, practical; bioresorbable, nontoxic wound protection; biocompatible fluid and gas; produces foam |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 04/29/2004 | WO2004035740A2 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035079A1 Treatment of osteoarthritis |
| 04/29/2004 | WO2004035077A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 04/29/2004 | WO2004035061A1 Method of administering bisphosphonates |
| 04/29/2004 | WO2004035029A1 Edible phosphoprotein film |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003055500A8 Pharmaceutical compositions for the treatment or prevention of osteoporosis |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | WO2003005966A9 Topical medicine and process and apparatus for making same |
| 04/29/2004 | WO2003003004A3 Method for identifying compounds the specifically deplete mast cells |
| 04/29/2004 | WO2002102787A3 Novel sulfonic acid derivatives |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082802 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 04/29/2004 | US20040082789 Thieno[2,3-c]iosquinolines for use as inhibitors of parp |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 04/29/2004 | US20040082642 Novel estrogen receptor ligands and method III |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082604 Antiarthritic agents; osteoporosis; immunosuppressants; antiinflammatory agents; autoimmunology diseases |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082588 Controlling concentration of calcium in blood |
| 04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082581 Controlling cell proliferation; antitumor agents |
| 04/29/2004 | US20040082579 Substituted-4-quinolones |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082550 Tropolone derivative |
| 04/29/2004 | US20040082545 Transferring sodium hydroxide solution to container; osteoporosis, antitumor agents |
| 04/29/2004 | US20040082540 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 04/29/2004 | US20040082523 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082511 Drug composition for the promotion of tissue regeneration |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082504 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081650 Inflammatory mediator antagonists |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | DE10246340A1 Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung Combination preparation of hyaluronic acid and at least one local anesthetic and its use |
| 04/29/2004 | CA2542513A1 Treatment of osteoarthritis |
| 04/29/2004 | CA2502356A1 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | CA2502084A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 04/29/2004 | CA2501381A1 Method of administering bisphosphonates |